Status:
COMPLETED
Intraoperative Norepinephrine Versus Fresh Frozen Plasma in Patients Undergoing HIPEC to Reduce Renal Insult
Lead Sponsor:
National Cancer Institute, Egypt
Conditions:
Anesthesia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
comparing the effect of low dose norepinephrine infusion versus fresh frozen plasma in patients undergoing HIPEC to reduce renal insult
Detailed Description
To compare the efficacy of maintaining intraoperative hemodynamic stability through infusing low dose norepinephrine versus fresh frozen plasma in patients undergoing cytoreductive surgery and heated ...
Eligibility Criteria
Inclusion
- ASA I and II
- World Health Performance Status ≤2
- scheduled for CRS/HIPEC operations
Exclusion
- patient's refusal
- allergy to any of the used drugs
- impaired renal or liver functions
Key Trial Info
Start Date :
October 20 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 28 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04683614
Start Date
October 20 2020
End Date
May 28 2022
Last Update
June 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Walaa Y Elsabeeny
Cairo, Egypt, 11796